Kongyuan Wei
Current Organizations / Institutes
The organizations/institutes from the scholar's latest article
Previous Organizations / Institutes
The organizations / institutes from the scholar's other articles in the past ten years
Kongyuan Wei has a total of 7 co-authors. Here are the top co-authors by number of shared publications:
- Bin Hu
Department of Clinical Laboratory Medicine, First affiliated Hospital of Xiamen University, Xiamen, China
1 shared publication Jinhui Tian
Evidence-based Medicine Center, School of Basic Medical Sciences
1 shared publicationKongyuan Wei
Department of General Surgery, First Affiliated Hospital of Lanzhou University
1 shared publicationShaobo Sun
Gansu university of Chinese Medicine, Lanzhou University, Lanzhou, China
1 shared publication- Xiaoying Si
Department of Hepatobiliary & Pancreatovascular Surgery, First Affiliated Hospital of Xiamen University, Xiamen, China
1 shared publication - Yanming Zhou
School of Clinical Medicine, Fujian Medical University, Fuzhou, China
1 shared publication
Latest Publications
- Open Access
- 26 November 2018
- Published by Springer Nature in BMC Gastroenterology
- Vol. 18 (1) , 1-6
Braun anastomosis lowers the incidence of delayed gastric emptying following pancreaticoduodenectomy: a meta-analysis
Delayed gastric emptying (DGE) is one of the most frequent complications following pancreaticoduodenectomy. This meta-analysis aimed to evaluate the impact of Braun enteroenterostomy on DGE following pancreaticoduodenectomy. A systematic review of the literature was performed to identify relevant studies. Statistical analysis was carried out using Review Manager software 5.3. Eleven studies involving 1672 patients (1005 in Braun group and 667 in non-Braun group) were included in the meta-analysis. Braun enteroenterostomy was associated with a statistically significant reduction in overall DGE (odds ratios [OR] 0.32, 95% confidence intervals [CI] 0.24 to 0.43; P <0.001), clinically significant DGE (OR 0.27, 95% CI 0.15 to 0.51; P <0.001), bile leak (OR 0.50, 95% CI 0.29 to 0.86; P = 0.01), and length of hospital stay (weighted mean difference -1.66, 95% CI -2.95 to 00.37; P = 0.01). Braun enteroenterostomy minimizes the rate and severity of DGE following pancreaticoduodenectomy.
- 26 November 2018
- Published by Springer Nature in BMC Gastroenterology
- Vol. 18 (1) , 1-6
Open AccessBraun anastomosis lowers the incidence of delayed gastric emptying following pancreaticoduodenectomy: a meta-analysis
Delayed gastric emptying (DGE) is one of the most frequent complications following pancreaticoduodenectomy. This meta-analysis aimed to evaluate the impact of Braun enteroenterostomy on DGE following pancreaticoduodenectomy. A systematic review of the literature was performed to identify relevant studies. Statistical analysis was carried out using Review Manager software 5.3. Eleven studies involving 1672 patients (1005 in Braun group and 667 in non-Braun group) were included in the meta-analysis. Braun enteroenterostomy was associated with a statistically significant reduction in overall DGE (odds ratios [OR] 0.32, 95% confidence intervals [CI] 0.24 to 0.43; P <0.001), clinically significant DGE (OR 0.27, 95% CI 0.15 to 0.51; P <0.001), bile leak (OR 0.50, 95% CI 0.29 to 0.86; P = 0.01), and length of hospital stay (weighted mean difference -1.66, 95% CI -2.95 to 00.37; P = 0.01). Braun enteroenterostomy minimizes the rate and severity of DGE following pancreaticoduodenectomy.
- Open Access
- 1 September 2018
- Published by Wolters Kluwer Health in Medicine
- Vol. 97 (38) , e12387
CT, MRI, and F-18 FDG PET for the detection of non-small-cell lung cancer (NSCLC) A protocol for a network meta-analysis of diagnostic test accuracy
Background: Non-small-cell lung cancer (NSCLC) is a rare cancer in lung carcinomas and has been widely known as a difficult curable disease among all the tumors. However, early detection of malignant potential in patients with NSCLC has still been a huge challenge all around the world. CT, MRI, and F-18 FDG PET are all considered as good tests for diagnosing malignant NSCLC efficiently, but no recommended suggestion presents that which test among the 3 is the prior one in diagnose. We perform this study through network meta-analysis method, and to rank these tests using a superiority index. Methods and analysis: PubMed, Embase.com, and the Cochrane Central Register of Controlled Trials (CENTRAL) will be searched from their inception to March 2018. We will include diagnostic tests which assessed the accuracy of CT, MRI, and F-18 FDG PET for diagnosing NSCLC. The risk of bias for each study will be independently assessed as low, moderate, or high using criteria adapted from Quality Assessment of Diagnostic Accuracy Studies 2 (QUADAS-2). Network meta-analysis will be performed using STATA 12.0 and R 3.4.1 software. The competing diagnostic tests will be ranked by a superiority index. Results: This study is ongoing, and will be submitted to a peer-reviewed journal for publication. Conclusion: This study will provide systematically suggestions to select different diagnostic measures for detecting the early NSCLC. Ethics and dissemination: Ethical approval and patient consent are not required since this study is a network meta-analysis based on published studies. The results of this network meta-analysis will be submitted to a peer-reviewed journal for publication.
- 1 September 2018
- Published by Wolters Kluwer Health in Medicine
- Vol. 97 (38) , e12387
Open AccessCT, MRI, and F-18 FDG PET for the detection of non-small-cell lung cancer (NSCLC) A protocol for a network meta-analysis of diagnostic test accuracy
Background: Non-small-cell lung cancer (NSCLC) is a rare cancer in lung carcinomas and has been widely known as a difficult curable disease among all the tumors. However, early detection of malignant potential in patients with NSCLC has still been a huge challenge all around the world. CT, MRI, and F-18 FDG PET are all considered as good tests for diagnosing malignant NSCLC efficiently, but no recommended suggestion presents that which test among the 3 is the prior one in diagnose. We perform this study through network meta-analysis method, and to rank these tests using a superiority index. Methods and analysis: PubMed, Embase.com, and the Cochrane Central Register of Controlled Trials (CENTRAL) will be searched from their inception to March 2018. We will include diagnostic tests which assessed the accuracy of CT, MRI, and F-18 FDG PET for diagnosing NSCLC. The risk of bias for each study will be independently assessed as low, moderate, or high using criteria adapted from Quality Assessment of Diagnostic Accuracy Studies 2 (QUADAS-2). Network meta-analysis will be performed using STATA 12.0 and R 3.4.1 software. The competing diagnostic tests will be ranked by a superiority index. Results: This study is ongoing, and will be submitted to a peer-reviewed journal for publication. Conclusion: This study will provide systematically suggestions to select different diagnostic measures for detecting the early NSCLC. Ethics and dissemination: Ethical approval and patient consent are not required since this study is a network meta-analysis based on published studies. The results of this network meta-analysis will be submitted to a peer-reviewed journal for publication.